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Aspirin exacerbated respiratory disease (AERD) is characterized by chronic hyperplastic rhinosinusitis, nasal polyposis, asthma,
and aspirin sensitivity. The mechanisms which produce these manifestations of intolerance are not fully deﬁned, current research
focuses on cyclooxygenase 1 (COX-1) inhibition, metabolism of arachidonic acid, and the COX pathway to the lipoxygenase
(LO) route, inducing increased synthesis of leukotrienes (LT). The biological plausibility of this model has led to the search for
polymorphisms in genes responsible for proinﬂammatory cytokines synthesis, such as IL1B and IL8.W ep e r f o r m e dag e n e t i c
association study between IL8-251 (rs4073) and IL1B-511 (rs16944) polymorphisms in AERD, aspirin-tolerant asthma (ATA), and
healthy control subjects. Using allelic discrimination by real-time PCR, we found statistically nonsigniﬁcant associations between
AERD, ATA, and healthy control subjects for the GG and GA genotypes of IL1B (rs16944). Interestingly, the AA genotype showed
an increased frequency in the AERD patients versus the ATA group (GF = 0.19 versus 0.07, p = 0.018, OR2.98, and 95% CI1.17–
7.82). This is the ﬁrst observation that IL1B polymorphisms are involved in AERD. Thus, future studies must investigate whether
interleukin-1β is released in the airways of AERD patients and whether it relates to genetic polymorphisms in the IL1B gene.
1.Introduction
Aspirin-exacerbated respiratory disease (AERD) is a syn-
drome characterized by chronic hyperplastic rhinosinusitis,
nasal polyposis, asthma, and aspirin sensitivity, as described
in 1922 by SzcZeklik et al. [1, 2]. The prevalence of AERD
is variable; Stevenson and Szczeklik reported in 2006 that
AERD occurs in 3% of adult patients with asthma in the
United States, with the onset of symptoms during the third
decade of life, and that it is more common in women than in
men, with approximately 70% versus 30% in Europe [2]a n d
57%versus43%intheUSA[3].Themechanismsunderlying
aspirin intolerance are not fully deﬁned, with current
research focusing on cyclooxygenase 1 (COX-1) inhibition
by aspirin and other NSAIDs diverting arachidonic acid
metabolism from COX pathways to the lipoxygenase (LO)
pathway. This leads to increased synthesis of the cysteinyl-
leukotrienes (LT), LTC4,L T D 4,a n dL T E 4, resulting in bron-
choconstriction, mucus hypersecretion, and possibly the
developmentofpolypsandurticaria[1].Thebiologicalplau-
sibility of this hypothesis fact has led to the search for poly-
morphisms in genes responsible for LT synthesis, to explore
associations between these polymorphisms and local tissue
levels of the proteins.
Other factors such as polymorphisms in the genes for
proinﬂammatory cytokines including TNF, IL1B, IL6, and
IL8 are involved in chronic inﬂammatory and autoimmune
diseases. Interleukin 1 (IL-1) is a cytokine associated with
inﬂammatory responses and found in two forms, IL-1α
(produced by the IL1A gene) and IL-1β (IL1B), with both2 Journal of Allergy
Table 1: Genetic data on SNPs investigated in study.
SNP Chr
Gene Alleles
Symbol Position Change Ancestral MAF
rs4073 4 IL8 −251 A/T A T = 0.492
rs16944 2 IL1B −511 G/A A A = 0.462
Chr: Chromosome, MAF: Minor allele frequency, MAF source: 1000 genomes phase 1 from dbSNP.
genes located on chromosome 2. IL-1 is expressed in nasal
polyps, nasal epithelium, macrophages, activated T lympho-
cytes, and monocytes; its expression is regulated by adhesion
molecules, and others inﬂammatory cytokines [4]. IL1B
polymorphisms have been associated with inﬂammatory
bowel disease and gastric cancer among other diseases
[5]. Recently, genetic polymorphisms in proinﬂammatory
cytokines such as IL-1β have been recognized as key players
in the pathogenesis of asthma [6]. Similarly, IL-8 has been
implicated in the asthmatic inﬂammatory process, and
genetic variation in this cytokine has been associated with
both the susceptibility and the severity of this disease [7].
In the present study, we have investigated the frequencies of
polymorphisms in the genes encoding these two cytokines in
AERD patients.
2.MaterialsandMethods
2.1. Subjects. Patients with aspirin-exacerbated respiratory
disease (AERD) (n = 78) and aspirin-tolerant asthma (ATA)
(n = 135) were recruited from the allergy and otolaryngol-
ogy departments at the Instituto Nacional de Enfermedades
Respiratorias (INER). Healthy control subjects (HCS) (n =
134) were invited to participate through AERD-screening
campaigns. All participants underwent simple spirometry,
inhaled methacholine challenge, and nasal challenge with
lysine-aspirin (L-ASA) according to international guidelines
to determine the degree of bronchial hyperresponsiveness
and conﬁrm AERD diagnosis. The AERD group had positive
L-ASA and methacholine challenges, the asthmatic group
had positive methacholine challenge, but negative L-ASA
challenge, and the healthy control subjects were volunteers
withnegativeL-ASAandmethacholinechallenges.Apositive
L-ASA challenge was deﬁned as a decrease of at least 40%
in total nasal airﬂow after L-ASA application compared with
baseline measures; methacholine challenge was considered
positive with a decrease of at least 20% in forced expiratory
volume in one second (FEV1) compared with baseline
FEV1 after the administration of diﬀerent concentrations
of methacholine (beginning with 0.03mg/mL, increasing
gradually the concentration twice every 2 minutes until the
concentration of 32mg/mL); in case it does not have it, it is
considered negative. Blood samples were collected for geno-
typing studies in the HLA laboratory research. The study
was approved by the science and bioethics committees of
INER,andallparticipantsgavetheirinformedconsent[8,9].
Patients and healthy control subjects had ancestry of at least
two generations born in Mexico and were thus considered to
be Mexican Mestizo in descent [10, 11].
2.2. DNA Extraction. Peripheral blood was drawn by
venipuncture, and genomic DNA was obtained using the
commercial BDtract DNA isolation kit (Maxim Biotech, San
Francisco, Calif, USA). The DNA was quantiﬁed by absorp-
tion of ultraviolet light at 260nm wavelength using an
ACTGene spectrophotometer (ACTGene, Inc., NJ, USA).
2.3. SNP Selection. We selected two polymorphisms in two
genes related to chronic inﬂammation: rs16944 in IL1B and
rs4073 in IL8. Genetic data from each of the polymorphisms
are described in Table 1.
2.4. Genotyping. Allelic discrimination of SNPs rs16944
(IL1B) and rs4073 (IL8) was performed by real-time PCR
(RT-PCR)ona7300RealTimePCRSystem(AppliedBiosys-
tems,Calif,USA)usingTaqmancommercialprobes(Applied
Biosystems, USA) for each of the polymorphisms mentioned
above and followed the cycling program: preread 50◦C, 1
minute; absolute quantitation: 50◦C, 2 minutes, 1 cycle;
95◦C, 10 minutes, 1 cycle; 95◦C, 15 seconds, 60◦C 1min, 40
cycles; postread 50◦C, 1 minute. The results were assessed
taking into account the allelic discrimination and absolute
quantitation in all samples; additionally, we included four
contamination controls per plate (nontemplate controls).
The interpretation was performed with Sequence Detection
Software (v. 1.4). The ﬂuorescence signal detectors used were
VIC which was assigned to the B allele and FAM assigned to
the A allele for both SNPs.
2.5. Statistical Analysis. Statistical analysis was performed
between groups of cases (AERD and ATA) versus the healthy
c o n t r o ls u b j e c t sb yχ2 test with 3 × 2 tables, using SPSS
(v. 15.0) software for Windows, to identify the diﬀerence
between the allele and genotype frequencies of each poly-
morphism evaluated. A p-value <0.05 was considered signif-
icant. In addition, odds ratios and 95% conﬁdence intervals
were calculated with Epi-info (v. 6.04) software.
3. Results
Clinical data for the three groups were compared and are
described in Table 2. We performed a genetic association
study of the IL8 (rs4073) and IL1B (rs16944) gene poly-
morphisms in the three groups. Genetic data for the SNPs
included in this study are shown in Table 1; minor allele
frequency (MAF) of the polymorphisms tested in healthy
control subjects had a similar distribution to that reported
in international databases (Table 1). Gene frequencies for
each genotype within the three subject groups are shown inJournal of Allergy 3
Table 2: Summary of clinical characteristics of AERD, ATA, and HCS.
AERD ATA HCS
Subjects 78 135 134
Gender (male/female) 31/47 49/86 79/55
Mean age (years, SD) 42.0 (14.4) 36.7 (17) 24 (8.9)
Premethacholine challenge FEV1 (%) 99.6 (17.3) 101.4 (12.9) 98.2 (13.3)
Postmethacholine challenge FEV1 (%) 75.1 (13.8) 76.9 (14.4) 95.4 (11.6)
Pre-L-ASA challenge nasal ﬂow (mL/sec) 640.75 (162.2) 689 (178.2) 670.2 (167.5)
Post-L-ASA challenge nasal ﬂow (mL/sec) 488 (142.8) 658.5 (186.3) 682.4 (165.7)
AERD: Aspirin-exacerbated respiratory disease, ATA: Aspirin-tolerant asthma, HCS: Healthy control subjects, SD: Standard deviation, FEV1:F o r c e d
expiratory volume in one second, L-ASA: Lysine aspirin.
Table 3: Genotype frequencies of IL8 and IL1B genes in AERD, ATA, and HCS.
Gene/SNP Genotype
AERD ATA HCS
n = 78 GF (%) n = 135 GF (%) n = 134 GF (%)
IL8
rs4073
AA 35 0.449 (44.87) 54 0.400 (40.00) 53 0.396 (39.55)
AT 33 0.423 (42.31) 57 0.422 (42.22) 63 0.470 (47.01)
TT 10 0.128 (12.82) 24 0.178 (17.78) 18 0.134 (13.43)
IL1B
rs16944
GG 23 0.295 (29.49) 57 0.422 (42.22) 47 0.351 (35.07)
GA 40 0.513 (51.28) 68 0.504 (50.37) 72 0.537 (53.73)
AA 15 0.192 (19.23) 10 0.074 (7.41) 15 0.112 (11.19)
AERD: Aspirin-exacerbated respiratory disease, ATA: aspirin-tolerant asthma, HCS: healthy control subjects, GF: genotype frequency.
Table 3. The frequency of genotypes AA, AT, and TT of the
IL8 rs4073 SNP was not statistically signiﬁcant and diﬀerent
between the three studied groups.
Analysis of GG and GA genotypes of the IL1B (rs16944)
SNP for AERD and ATA patients versus the healthy con-
trol subjects showed nonstatistically signiﬁcant associations.
Interestingly, the AA genotype showed increased frequency
in the AERD patients when compared to the ATA group
(GF = 0.19 versus 0.07); this association was statisti-
cally signiﬁcant (p = 0.018, OR 2.98, and CI 1.17–7.82)
(Tables 3 and 4)a n dw a sn o tf o u n dw h e nA E R Do rA T A
groups were compared to healthy control subjects. There is
nodiﬀerenceinAAversusAG+GGusingcontrastofhealthy
control subjects versus AERD patients (data not shown).
4. Discussion
The airways of aspirin-sensitive patients are characterized
by chronic inﬂammation with cell inﬁltration even when
they are not exposed to aspirin or other NSAIDs [12]. In
additiontoalterationsinthemetabolismofarachidonicacid,
severalproinﬂammatorycytokineshavebeenassociatedwith
AERD. The role of IL-1, however, has not been investigated
previously. Here, we report that AERD patients show an
increasedfrequencyoftheIL1B-511polymorphism(rs16944
AA genotype) compared to aspirin-tolerant asthmatics.
Interleukin-1β has been reported to be involved in the
genesis of both asthma [13, 14] and chronic rhinosinusitis
with nasal polyposis in a Turkish population [15]. Most
studies have attempted to establish the association of poly-
morphisms in the IL1B promoter gene, mainly at positions-
511 G/A (rs16944) and -31 C/T. For example, Park et al.,
in 2004, did not ﬁnd any association between these polymor-
phisms and either asthma or atopy in a Korean population
[16]. In 2007, Erbek et al. described a susceptibility for
developing nasal polyps associated with the IL1B-511 poly-
morphism (rs16944) [15], but Mfuna Endam et al., in 2010,
failed to reproduce this ﬁnding in Canadian patients with
chronic rhinosinusitis [17]. In 2003, Allen et al. did not ﬁnd
any association with IL1 gene polymorphisms in asthmatic
families (n = 244), but they reported an association with
the DNA microsatellite D2S308 in these asthma families
(p = 0.00001) [18]. In parallel, Karajalein et al. evaluated
245 patients with asthma and nasal polyposis and did not
ﬁnd any association between the polymorphism IL1B-5114 Journal of Allergy
Table 4: Statistical association of IL1B rs16944 AA in AERD and ATA patients.
Gen/SNP
AERD ATA
P OR CI (95%)
n = 78 GF (%) n = 135 GF (%)
IL1B/rs16944
AA 15 0.192 (19.23) 10 0.074 (7.41) 0.018 2.98 1.17–7.82
AERD: Aspirin-exacerbated respiratory disease, ATA: aspirin-tolerant asthma, GF: genotype frequency, p value Yates correction’s, OR: odds ratio, 95% IC:
95% Conﬁdences Interval.
C/T and nasal polyps [19]. Evidence for the role of IL-1 in
pulmonary immune responses has been gathered in murine
models of allergic asthma using IL-1R1-deﬁcient [IL-1R1
(−/−)] mice; changes observed in these mice include sig-
niﬁcant reduction of pulmonary eosinophilic inﬂammation,
diminished goblet cell hyperplasia, and reduction of cell
recruitment to the lungs, as compared to control BALB/c
mice [20]. However, there are no studies linking gene pro-
moter polymorphisms and levels of expression of the
cytokine in the lung microenvironment.
In the present study, we have demonstrated that the
frequency of the IL1B-511 polymorphism (rs16944 AA
genotype) is three-fold higher in AERD (19.2%) than in ATA
patients (7.4%), suggesting that patients carrying this poly-
morphism may exhibit genetic susceptibility to develop
AERD.
Findings on the biological functionality of the rs16944
polymorphism have not been consistent across studies.
The AA genotype has been associated with higher gastric
mucosal levels of IL-1β in bacterial infections [21], while
mononuclear cells from subjects with the GG genotype
showed an increased release of IL-1β after stimulation with
lipopolysaccharide[22].Recentstudiessuggestthatthefunc-
tional role of rs16944 may depend on IL1B promoter region
haplotypesincludingrs16944[23–26].Althoughtheﬁndings
are inconsistent, these previous studies suggest that rs16944
could aﬀect the expression levels of IL-1β. Our report is the
ﬁrst demonstration of the involvement of IL1B polymor-
p h i s mi nA E R D .T h es a m p l es i z ei sr e l a t i v e l ys m a l l ,p a r t i c -
ularly in the AERD group, which may limit the statistical
power, so it would be desirable to replicate our ﬁndings in
an independent population.
Future studies must investigate whether this cytokine is
released in the airways of AERD patients and whether its
levels relate to genetic polymorphisms in the IL1B gene.
Interleukin-8 has been implicated in asthma and found
in high concentrations in bronchoalveolar lavage ﬂuid of pa-
tients with acute asthma exacerbations [26]. In fact, poly-
morphic IL8 alleles (−251T and 781C) have been associated
with asthma in a European population [7, 27], but not in
asthmatics of Korean origin [7]; the diﬀerences could be
explained by the diﬀerent ethnic populations studied. In
contrast, Korean asthmatics were found to show four non-
synonymous amino acid substitutions in the IL-8 receptor A
(IL8RA) and an association of one synonymous variation in
IL8RB[28]. In the present study, we did not ﬁnd a signiﬁcant
diﬀerence in the rs4073 A/T between the AERD group and
ATA patients.
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